News Release
ORIX Life to Launch the Industry’s First* Cancer Insurance “Canvas” with All Coverage Beginning on the First Day of Enrollment
~ Allowing individuals to prepare by freely combining their necessary insurance ~
Aug 06, 2026
TOKYO, Japan – August 6, 2026 – ORIX Life Insurance Corporation (“ORIX Life”) announced today that it will launch the cancer insurance “Canvas” on October 2, 2026. “Canvas” is the life insurance industry’s first cancer insurance to provide all coverage from the first day of enrollment, with no waiting period.

“Canvas” is available in two types: a treatment benefit type that offers monthly benefits in preparation for continuous treatment, such as outpatient cancer treatment; and a diagnosis benefit type that offers a lump-sum benefit when diagnosed with cancer. Furthermore, to provide coverage after a cancer diagnosis, seven types of riders can be freely combined, including insurance coverage for hospitalization due to illnesses and injuries other than cancer and for optional treatment that is not covered by public health insurance, in addition to coverage for hospitalization due to cancer. This allows flexible insurance design in accordance with the needs of each customer.
Cancer insurance in the past was usually designed with a certain waiting period after enrollment before coverage begins, and lack of coverage immediately after enrollment was an issue. ORIX Life has eliminated waiting periods for all coverage by further strengthening the accuracy of its management of underwriting and payment risks through efforts such as analyzing claim and payment data and reviewing the information applicants are required to disclose. This allows customers to have cancer coverage from the first day of enrollment.
ORIX Life will continue to develop products that meet customer needs and take on new challenges—such as providing industry-first coverage—while striving to remain an insurance company that customers continue to choose.
* This is the first cancer insurance in the life insurance industry that does not have a waiting period after enrollment for all coverage, including lump-sum benefits for cancer diagnosis (as of August 2026, according to research conducted by ORIX Life).
Contact Information:
Investor Relations Department
ORIX Corporation
Tel: +81-3-3435-3121
About ORIX Group:
ORIX Group (ORIX Corporation TSE: 8591; NYSE: IX) was established in 1964 and has grown from its roots in leasing in Japan to become a global, diverse, and unique corporate group. Today, it is active around the world in financing and investment, life insurance, banking, asset management, real estate, concession, environment and energy, automobile-related services, industrial/ICT equipment, ships and aircraft. Since expanding outside of Japan in 1971, ORIX Group has grown its business globally and now operates in around 30 countries and regions across the world with approximately 37,000 people. ORIX Group unites globally around its Purpose: “Finding Paths. Making Impact.” combining diverse expertise and innovative thinking to help our world develop in a sustainable way.
For more details, please visit our website: https://www.orix.co.jp/grp/en/
(As of March 31, 2026)
Caution Concerning Forward-Looking Statements:
These documents may contain forward-looking statements about expected future events and financial results that involve risks and uncertainties. Such statements are based on our current expectations and are subject to uncertainties and risks that could cause actual results that differ materially from those described in the forward-looking statements. Factors that could cause such a difference include, but are not limited to, those described under “Risk Factors” in the Company’s annual report on Form 20-F filed with the United States Securities and Exchange Commission and under “(4) Risk Factors” of the “1. Summary of Consolidated Financial Results” of the “Consolidated Financial Results April 1, 2025 – March 31, 2026” furnished on Form 6-K.
- View PDF of this release
- PDF
[239KB]
- PDF